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ABSTRACT 
Tissue oxygen (O2) levels vary during development and disease; adaptations to decreased O2 (hypoxia) are 
mediated by hypoxia-inducible factor (HIF) transcription factors. HIFs are active in the skeleton, and stabilizing 
HIF- isoforms cause high bone mass (HBM) phenotypes. A fundamental limitation of previous studies 
examining the obligate role for HIF- isoforms in the skeleton involves the persistence of gene deletion as 
osteolineage cells differentiate into osteocytes. Because osteocytes orchestrate skeletal development and 
homeostasis, we evaluated the influence of Vhl or Hif1a disruption in osteocytes. Osteocytic Vhl deletion 
caused HBM phenotype, but Hif1a was dispensable in osteocytes. Vhl cKO mice revealed enhanced canonical 
Wnt signaling. B cell development was reduced while myelopoiesis increased in osteocytic Vhl cKO, revealing 
a novel influence of Vhl/HIF- function in osteocytes on maintenance of bone microarchitecture via canonical 
Wnt signaling and effects on hematopoiesis. 
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1. INTRODUCTION
Oxygen (O2) levels vary throughout the body. They change spatiotemporally during development, and 
can be acutely impacted during pathophysiological insults, such as stroke or bone fracture. Adaptive 
responses to decreased O2 (hypoxia) are rectified by transcriptional induction of genes promoting 
angiogenesis and anaerobic glycolysis, which are mediated, in part, by the hypoxia-inducible factor 
(HIF) family of transcription factors[1]. Constitutively expressed HIF- subunits bind to one of three 
distinct HIF- isoforms (HIF-1, HIF-2, and HIF-3) to initiate gene expression, although HIF-3 is 
considered an inhibitor of HIF-1 and HIF-2. Oxygen levels regulate HIF-responsive gene 
expression. Under normoxic conditions, HIF- subunits are proline hydroxylated by proline 
hydroxylase-domain proteins (PHDs), targeted for ubiquitination by the E3 ligase complex von 
Hippel-Lindau (Vhl) and are ultimately degraded by the 26S proteasome. Under hypoxic conditions, 
prolyl hydroxylation of HIF- is inhibited, enabling HIF- to accumulate, translocate into the nucleus and 
complex with HIF-/ARNT, and ultimately bind to HIF-response elements (HRE) within target genes.  
The VHL/HIF system is highly active in the skeleton. Multiple strategies that use osteolineage-
specific cre drivers and deletion of PHD or Vhl to stabilize HIF-1 and HIF-2 increase bone 
mass. Individually or combinatorially deleting Phd1, Phd2, or Phd3 in Osterix-positive 
osteoprogenitors improves trabecular microarchitecture dependent upon the degree of HIF- 
stabilization[2]. Similarly, deletion of Vhl in mature osteoblasts using an osteocalcin (Bglap) cre driver 
increases trabecular and cortical microarchitecture[3].  
The murine models described above clearly demonstrate that manipulating HIF- levels in bone 
cells influences skeletal development and homeostasis. In these models, Vhl or Phd isoform elimination 
persists as osteoprogenitors differentiate into osteoblasts and then transition into osteocytes. Thus, 
these models cannot elucidate the influence of Vhl deletion in osteocytes compared to Vhl 
deletion in osteoprogenitors or osteoblasts. Osteocytes are the most abundant cells within bone, 
comprising >90% of total cells[4]. Osteocytes exert critical roles in mechano-sensing, skeletal 
remodeling, mineral homeostasis and hematopoiesis[5]. Indeed, the osteocyte and the extensive 
osteocytic network in bone is now recognized as a central regulator of skeletal activity[5,6]. The 
frequency of HIF-1-positive osteocytes increases in mice under disuse conditions[7]; in vitro, 
exposing osteocyte-like cells to hypoxia augments secretion of chemotactic factors[8] and GDF15 to 
promote osteoclastogenesis[9], and influences the osteoblast-to-osteocyte transition[10]. Other osteocytic 
functions attributed to HIF- function include directing appropriate bone formation in response to 
mechanical loading[11], sensing microdamage[12], and development of the lacunocanalicular network in 
which osteocytes reside[13]. 
Provided the recognition that osteocytes orchestrate many aspects of skeletal development 
and homeostasis, we sought to evaluate the influence of Vhl or Hif1a disruption in osteocytes. We used a 
cre-loxP system under control of the non-inducible 10kb-Dmp1 promoter[14] to  address the function of 
Vhl in osteocytes. Similar to results using Bglap-cre to delete Vhl in mature osteoblasts[3], osteocytic 
deletion of Vhl produced mice with a high bone mass (HBM) phenotype that dramatically increased 
trabecular and cortical microarchitecture. Femoral osteocytes in Vhl cKO mice revealed qualitative 
and quantitative reductions in sclerostin immunostaining, and concomitant increases in activated -
catenin levels, suggesting that Vhl/HIF- signaling influences canonical Wnt signaling in osteocytes. Vhl 
cKO mice mated to mice lacking the Wnt co-receptor Lrp5 or to transgenic mice over-expressing the 
human SOST gene revealed that Vhl functions epistatically to canonical Wnt signaling: cortical 
microarchitecture resolved to wild-type phenotype in compound mice, but not trabecular 
microarchitecture. Osteocytic HIF-  contributes to hematopoiesis, as B cell development is 
blocked in osteocytic Vhl cKO mice. These data reveal a novel influence of Vhl/HIF- function in 
osteocytes on maintenance of bone microarchitecture via canonical Wnt signaling and effects 
on hematopoiesis. 
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2. MATERIALS AND METHODS
Mice
Vhlhf/f[15] (#004081) and Hif1af/f[16] (#007561) were purchased from Jackson Laboratories and bred to 
control C57Bl/6 or with mice expressing cre recombinase from the 10kb-Dmp1 promoter (Dmp1-cre) 
[B6N.FVB-Tg(Dmp1-cre)1Jqfe/BwdJ] [14] (kindly provided by Dr. Jian Q. Feng, Department of Biomedical 
Sciences, Texas A&M University Baylor College of Dentistry) to generate Dmp1-cre; Vhlhf/f and Dmp1-cre; 
Hif1af/f mice with osteocyte conditional deletion of Vhlh (hereafter, Vhl cKO) or Hif1a (Hif1a cKO). Mice globally 
deficient for Lrp5 have been previously described (Lrp5tm1.2Vari;kindly provided by Dr. B. Williams[17]); mice 
over-expressing human SOST under control of a BAC have been described previously [18,19]. All animal 
experimental procedures were completed under an approved protocol by the IACUC committees at Lawrence 
Livermore National Laboratory and University of California, Merced and conform to the NIH Guide for the Care 
and Use of Laboratory Animals. All animals used in this study were 3.5-4 months of age at analysis. 
Immunocytochemistry, histology, and immunohistochemistry 
Femur and L4 lumbar vertebrae were collected at 16 weeks of age from male mice, and fixed, dehydrated, 
embedded and sectioned as previously described[18]. Detailed description of immunocytochemistry is 
available in Supplemental Information. Hematoxylin and eosin (Sigma) staining was performed as in [19]; 
MacNeal’s tetrachrome/Von Kossa staining and toluidine blue staining were performed as described in [20]. 
Dynamic histomorphometry was performed and analyzed as in[21]. 
Micro-computed tomography (µCT) 
At euthanasia, the right femur was extracted, placed in 10% neutral-buffered formalin for two days, and 
then stored in 70% ethanol at 4°C. A 2.6-mm span of the distal femoral metaphysis was scanned on a high 
resolution μCT (μCT 35; Scanco Medical AG) at 13μm resolution using 50kV peak tube potential and 151ms 
integration time to measure trabecular three-dimensional morphometric properties as described in [21].  
Isolation of Bone Marrow Cells and Splenocytes and Flow Cytometry 
Bone marrow cells and splenocytes were isolated as in[22]. Both BM cell and splenocyte suspensions were 
filtered through 70 micron nylon mesh squares into clean 15 ml conical tubes. Total cell counts were obtained 
using a hemocytometer and Trypan Blue staining to exclude dead cells. Detailed description of antibodies and 
staining parameters are available in Supplemental Information. Cells were acquired on a Becton Dickinson 
LSR II and flow cytometric analysis was performed using FlowJo software. 
Statistical Analysis 
All data were expressed as the mean + standard deviation. Unpaired Student’s t-test, or one-way ANOVA 
followed by Fisher’s LSD test were used where appropriate. For flow cytometry results, statistical analysis was 
done using Student’s t-test with a two-tailed distribution, with two-sample equal variance (homoscedastic test). 
For all tests, p< 0.05 was considered statistically significant. 
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3. RESULTS
Deletion of Vhl in osteocytes has robust effects on trabecular and cortical microarchitecture
Deletion of Vhl and subsequent stabilization of HIF-1 and HIF-2 in mature osteoblasts promotes bone 
modeling and accrual, whereas deletion of Hif1a produces an inverse skeletal phenotype[3]. Because Vhl 
deletion in mature osteoblasts persists as osteoblasts differentiate into osteocytes, previous data do not 
identify the  impact of osteocytic Vhl deletion on skeletal mass and architecture. In order to examine the impact 
of Vhl and Hif1a expression in osteocytes, we used a cre-loxP system wherein cre recombinase was 
expressed under control of the 10kb-Dmp1 promoter[14]. Immunofluorescent staining of Vhl was 
decreased in sections from Vhl cKO mice compared to cre-negative control mice (Figure 1A); conversely, 
staining for HIF-1or HIF-2 was more robust in Vhl cKO sections. The fraction of osteocytes staining 
positively for HIF-1 or HIF-2in Vhl cKO animals (Figure 1C) increased; consistent with observations by Wu 
et al.[2], not all osteocytes were immunoreactive for HIF-1 or HIF-2.  
Hematoxylin and eosin staining revealed gross changes in cortical and trabecular phenotype in Vhl cKO 
mice compared to cre-negative control mice in both the appendicular (Figure 2A) and axial (Supplemental 
Figure 1B) skeleton. Vhl cKO bones showed extensive endomucin immunoreactivity (Figure 2B), indicating 
increased vascularization. Sagittal and transverse microCT sections of the distal femur revealed a robust 
increase in trabecular bone volume fraction in Vhl cKO mice compared to wild-type mice (Figures 2C and 2D); 
trabecular thickness (Figure 2E) and number (S2A) were also increased in Vhl cKO mice, with concomitant 
decreases in trabecular spacing (S2B). Cortical microarchitecture was also influenced by Vhl deletion in 
osteocytes. Total cross-sectional area (Tt.Ar, Figure 2F), cortical bone area (Ct.Ar; Figure 2G), and cortical 
thickness (Figure 2H) each increased in cKO mice relative to cre-negative mice. Polar moment of inertia, 
which quantifies the expected resistance to torsional loads, also increased in Vhl cKO mice (Figure 2I).  
The severe HBM phenotype observed in osteocytic Vhl cKO mice prompted us to evaluate the mechanism 
of rampant bone accumulation in order to determine whether the phenotype is driven largely by a deficiency in 
osteoclastic bone resorption. Von Kossa/MacNeal’s tetrachrome staining of the distal femur revealed calcified 
matrix (bone or cartilage) in osteocytic Vhl cKO compared to cre-negative mice (S2D). Toluidine blue staining 
showed no evidence of residual calcified cartilage (Figure S2E), a hallmark of osteoclastic defects as sin many 
forms of osteopetrosis. In contrast, the pale blue staining of the mineralized portion of the metaphysis indicates 
that the cancellous bone comprises secondary, remodeled bone. In contrast, note the dark blue staining of the 
epiphyseal plate (S2E). These data demonstrate that manipulating HIF- function in osteocytes exerts a strong 
influence on skeletal microarchitecture and vascularity. 
Osteocytic Hif1a does not contribute to skeletal development. 
Previous works examining the influence of HIF- function in bone have reported an inverse phenotype in 
animals lacking Vhl compared to animals lacking HIF- isoforms. Where Bglap-cre; Vhlhf/f animals have a high 
bone mass phenotype, Bglap-cre;Hif1af/f animals have low bone mass and inferior skeletal microarchitecture 
[3]. Because Vhl cKO mice displayed a high bone mass phenotype, we expected mice lacking Hif1a in 
osteocytes to have an osteoporotic phenotype. Unexpectedly, we found that Dmp1-cre; Hif1af/f mice were 
phenotypically indistinguishable from cre-negative control mice (Figure 3A), with no significant differences in 
trabecular bone volume fraction (Figure 3B), cortical area fraction (Figure 3C), or bone formation rate (Figure 
3D). The absence of a skeletal phenotype in osteocytic Hif1a cKO mice, compared to the reported low bone 
mass phenotype of osteoblastic Hif1a cKO mice[3], suggests that osteocytes utilize an alternate HIF- isoform, 
or HIF-independent signaling, to influence the skeleton.  
Osteocytic Vhl regulates canonical Wnt signaling 
Activation of Wnt signaling occurs during load-induced bone formation[23] and is required for new bone 
deposition in response to external loads[24,25]. Although osteocytes do not directly contribute to bone 
formation, osteocytic -catenin is required for the osteoanabolic effect of mechanical loading[26], and 
constitutively active -catenin in osteocytes increases both cortical and trabecular bone mass through 
increasing both arms of remodeling[27]. To identify a role for Wnt signaling in the observed HBM phenotype, 
we evaluated Sclerostin and activated -catenin levels in decalcified sections of cre-negative and Vhl cKO 
femora by immunocytochemistry. Sclerostin immunoreactivity was markedly decreased in Vhl cKO osteocytes 
compared to cre-negative mice (Figures 4A and S5A), whereas there was a concomitant increase in 
osteocytes staining for activated -catenin, suggesting that osteocytic Vhl could function epistatically to 
reciprocally regulate Sclerostin expression and canonical Wnt signaling.  
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To determine if Vhl-mediated changes in Wnt signaling were correlative or causative for the observed HBM 
phenotype, we mated Vhl cKO mice to mice with impaired Wnt signaling, achieved via SOST over-expression 
(SOSTTG)[28] or Lrp5 deletion (Lrp5-/-)[25]. Both Lrp5 deficiency and SOST overexpression blunted the HBM 
phenotype of Vhl cKO but failed to fully resolve the HBM phenotype (Figure 4B). Compound Vhl/Wnt mutant 
mice revealed compartment-specific restoration of skeletal microarchitecture, wherein trabecular 
microarchitecture in compound mice had an intermediate HBM phenotype (Figures 4B-4D; S5B and S5C); in 
contrast, the cortical microarchitecture was indistinguishable from wild-type mice, (Figures 4B, 4E, and 4F; 
S5D and S5E). These results suggest that trabecular anabolic effects of Vhl deficiency do not exclusively 
depend on Wnt signaling via the Lrp5 co-receptor, but may require additional Wnt-signaling receptors/co-
receptors, or may occur via non-canonical mechanisms. 
Cell-extrinsic effects of osteocytic Vhl deletion on hematopoiesis 
The integrity of the bone marrow microenvironment is critical for the maintenance of hematopoietic stem 
cells and their differentation into specific immune cell types and erthryocytes. The severely reduced bone 
marrow cavity volume of the Vhl cKO (Figure 5A) is similar to the phenotype observed in Sost-/- [22] and Prx1-
cre; Sostf/f[29] mice. Absolute numbers of total bone marrow cells (Supplemental Table 1), CD45+ 
hematopoietic cells (Figure 5B), and total CD19+ B lymphocytes (Supplemental Table 1) were significantly 
reduced in the marrow of the Vhl cKO mice. B cell maturation—distinguished by cell surface expression of 
B220 and IgM into “precursor” (B220int IgM-), “immature” (B220int IgM+) and “mature” (B220high IgM+) stages— 
was decreased in bone marrow of Vhl cKO mice (Figures 5C and 5D). Further, we observed greater 
proportions of monocytes and granulocytes and an overall reduction in the numbers of all hematopoietic 
lineages in the bone marrow of Vhl cKO mice (TABLE 1). Total splenocyte number and distributions of 
hematopoietic lineage cells were altered in the spleen of Vhl cKO mice (Supplemental Table 2). The 
proportion of LSK (Lineage-negative Sca1high cKithigh) hematopoietic progenitors increased in both the bone 
marrow and the spleens of Vhl cKO mice (Figure 5E), whereas the absolute numbers of LSKs in the bone 
marrow of cre-negative and Vhl cKO mice were similar (S6B and S6C).  
Although Vhl deletion was targeted to the bone, B cell development in the spleen were affected by 
osteocytic Vhl deletion. Total splenocyte number and distributions of hematopoietic lineage cells were altered 
in the spleen of Vhl cKO mice (Supplemental Table 2).  Splenic CD19high B220high cells were reduced relative 
to control animals (Figure 5F), indicating a reduction of mature B cells. However, further investigation with 
additional cell surface markers demonstrated that within mature splenic B cells, there was an increase in the 
proportion of IgM+IgDlow cells (Figure 5G), indicating an immature phenotype. Evaluating CD19int B220int 
populations revealed cells in Vhl cKO spleens expressing an IgM+ IgDlow staining pattern (Figure 5G), 
reminiscent of the staining pattern found on plasma B cells and the “natural antibody” producing innate-like B-1 
B cells, which are normally not found in the spleen [30]. Taken together, our data demonstrate that osteocytic 
Vhl deletion has dramatic effects on hematopoiesis in the bone marrow, and suggests that these changes in 
the bone marrow result in major effects on hematopoiesis and B cell development in the spleen. 
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4. DISCUSSION
Osteocytic Vhl contributes to skeletal development. 
Stabilizing HIF- isoforms, via deletion of Phd1, Phd2, or Phd3[2], or Vhl[3], produced HBM mice, which 
affected both trabecular and cortical bone. Osteoblastic Vhl deletion also increased bone formation in response 
to distraction osteogenesis[31], and pharmacologic activation of HIF-s increased bone volume in distraction 
gaps[31,32] and fracture callus[33]. Thus, using genetic and pharmacologic means, it is clear that stabilizing 
HIF- isoforms influences skeletal microarchitecture, demonstrating the fundamental requirement for HIF- 
isoforms in skeletal development, homeostasis, and repair. Yet, how osteocytes, embedded within the 
skeleton, use pericellular oxygen levels and HIF- stabilization as a guide for skeletal homeostasis remains 
unexamined. Further, deleting proteins in osteoprogenitors or osteoblasts that regulate HIF- stability, such as 
Vhl[3] or PHD isoforms[2], creates osteocytes deficient in said proteins; thus, previous studies have not been 
able to evaluate the contribution of osteocytic HIF- signaling toward skeletal development. While there are 
reports of 10kb-Dmp1-cre expression in mature osteoblasts[34] and non-skeletal tissues (Pdfgra-expressing 
gastrointestinal mesenchyme, and portions of the hindbrain)[35], and this study did not evaluate the potential 
role of non-skeletal Dmp1-cre expression and Vhl excision on the observed skeletal phenotype. With respect to 
Dmp1-cre expression in osteoblasts, we find no skeletal phenotype in Dmp1-cre; Hif1a cKO mice, in contrast 
to work using Bglap-cre; Hifa cKO mice, suggesting that modest Dmp1-cre activity in osteoblasts is inadequate 
to counterbalance the effect of excision in osteocytes. Thus, our results demonstrate that HIF- signaling in 
osteocytes has tremendous impact on skeletal development, recapitulating the high bone mass phenotype 
observed when Vhl is deleted in mature osteoblasts[3].  
Differential requirement for HIF- isoforms in osteolineage cells 
Osteocytic Vhl deletion stabilizes HIF- isoforms and produces a HBM phenotype. Thus, we anticipated 
that osteocytic Hif1a deletion would produce an inverse phenotype, as occurs in mice in which Vhl vs. Hif1a 
are deleted in mature osteoblasts under control of the Bglap-cre driver[3]. In stark contrast to these results, 
osteocytic Hif1a cKO mice showed no skeletal phenotype, and were phenotypically identical to cre-negative 
mice. Although not conclusive, these results suggest that osteocytes utilize an alternate HIF- isoform—
specifically HIF-2—to produce the HBM phenotype observed in osteocytic Vhl cKO mice. Indeed, our results 
and other results in osteoprogenitors and mature osteoblasts suggest that HIF- isoforms are differentially 
required by osteoprogenitors, mature osteoblasts, and osteocytes. Deleting Phds or Vhl increases cortical and 
trabecular bone in each model [2,32], and our results, but deletion of Hif1a or Hif2a exerts osteolineage-
specific effects on the skeleton. In osteoprogenitors (Osx-cre), individual deletion of Hif1a or Hif2a had no 
effect on trabecular bone[2]. In mature osteoblasts (Bglap-cre), deleting Hif1a decreased trabecular bone 
volume fraction (Tb.BV/TV) and cortical cross-sectional area; Hif2a deletion moderately affected trabecular or 
cortical bone[36]. We observe a high bone mass (HBM) phenotype in osteocytic Vhl cKO, but absence of an 
inverse phenotype in osteocytic Hif1a cKO mice. This scenario is similar to what is observed during the 
osteoblast-to-osteocyte transition[34,37]; indeed, Hif1a transcript decreases 55% during the osteoblast-to-
osteocyte transition, whereas Hif2a levels increase 265% (data from GSE54784[37]). Alternately, HIF--
independent functions of Vhl, such as stabilization of Ndrg3[38], may contribute to the Vhl cKO HBM 
phenotype.. 
Functional integration of Vhl and Wnt signaling 
Both Vhl/HIF-[3] and Wnt/Lrp5[39] signaling robustly influence skeletal development. Our results suggest 
that these osteoanabolic pathways are epistatic: Vhl cKO animals demonstrate decreased immunostaining for 
the Wnt receptor antagonist Sclerostin and concomitant increases in levels of activated -catenin. We have 
previously reported similar results in vitro, wherein culturing clonal mature osteoblasts similarly decreases Sost 
transcript levels and increases activated -catenin levels[40]. Yet, the epistatic relationship that we report 
within is likely highly context-dependent, depending on, for example, the cre driver used and the osteogenic 
differentiation state of the cells in which oxygen sensing is manipulated. For example, Riddle et al. reported 
that HIF-1 antagonizes load-induced -catenin signaling[11], and hypoxic induction of MC3T3-E1 pre-
osteoblasts induces Sclerostin expression to reduce Wnt signaling[41]. Similarly, Vhl deletion in 
osteochondroprogenitors (Col2a1-creERT2) has an osteoanabolic effect on trabecular, but not cortical, bone[42]. 
We observe skeletal compartment-specific influence of Vhl deletion on Wnt signaling. In both models Vhl 
cKO; Lrp5-/- or Vhl cKO; SOSTTG mice, cortical microarchitecture is phenotypically normalized to mirror the 
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microarchitecture of wild-type mice, whereas trabecular phenotype is partially rescued. Compartment-specific 
effects of Wnt signaling have previously been reported: Wnt16-/- mice have decreased cortical, but not 
trabecular bone mass[43]; additionally, over-expression of the Wnt antagonist sFrp4 decreases trabecular 
microarchitecture without affecting cortical mass or geometry[44]. The fundamental cause of compartment-
specific effects on microarchitecture remain unknown, and are attributed to differential expression of Wnt 
ligands or antagonists[43], turnover rate, and proximity to the bone marrow niche and vascular network. 
Normalization of cortical microarchitecture in Vhl/Wnt compound mutant mice suggests that Vhl signaling is 
more fully epistatic in cortical bone than in trabecular bone.  
Osteocytic regulation of hematopoiesis 
Osteoblasts and osteocytes regulate hematopoiesis. Mice expressing a constitutively-active parathyroid 
hormone (PTH)/PTH-related peptide (PTHrP) receptor PTH1R under control of the type I collagen 2.3kb 
promoter have increased LSK population of hematopoietic stem cells in bone marrow[45]. In the absence of 
genetic manipulation, administering PTH to calvarial explants in vitro increases B lymphopoiesis [46]. 
Conversely, disrupting Gs-alpha subunit signaling in pre-osteoblasts[47], or conditional osteoblast ablation[46], 
decreases B cell progenitors. In osteocytes, Gs signaling regulates myelopoiesis, demonstrated through 
increased granulocytes and platelets in the peripheral blood, as well as splenomegaly[48]; this occurs 
independently of osteocytic PTH1R signaling, as such transgenic mice reveal no HSC abnormalities[49]. 
Similarly, osteocytic RANKL (Tnfsf11) is necessary for ovariectomy-induced B cell expansion[50], and 
osteocyte ablation decreases B lymphopoiesis and thymocyte depletion[51]. Our data suggest that the Vhl cKO 
microenvironment skews HSCs to the myeloid lineages at the expense of lymphoid development. T 
lymphocyte development appears normal, and only B cell development is affected in Vhl cKO mice. Eludication 
of the molecular programs within osteocytes that drive hematopoiesis require extensive analysis of purified 
adult hematopoietic niche cells such as mesenchymal stem cells, osteoblasts and endothelial cells[52]. Taken 
together, these data suggest that structural aspects of the bone are important in the regulation of 
hematopoietic stem cells and immune cell development, but the specific role of Vhl deletion osteocyte function, 
and how this alters the function of HSCs, B cell progenitors and progeny is still unknown. Further studies are 
required to determine the molecular mechanisms underlying the effects of acute bone remodeling on 
hematopoiesis. 
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FIGURE LEGENDS 
Figure 1. Inverse expression of HIF-1 and HIF-2 in osteocytic Vhl cKO mice. (A) Representative 
immunofluorescent staining for Vhl, HIF-1 and HIF-2 staining in femoral mid-diaphyseal cortical bone from 
cre-negative or osteocytic Vhl cKO mice. (B) Quantification of osteocytes staining positively for HIF-1 and 
HIF-2 in cre-negative or Vhl cKO femoral mid-diaphyseal cortical bone. n=3-5 mice per genotype; groups with 
different letters are statistically different from each other. 
Figure 2. Systemic influence of osteocytic Vhl deletion. (A) Representative hematoxylin- and eosin-stained 
distal epiphysis from 16-week old male cre-negative and Vhl cKO mice. (B) Representative staining for the 
endothelial cell marker endomucin in the proximal metaphysis of cre-negative and Vhl cKO mice. (C) microCT 
images illustrate the influence of osteocytic Vhl deletion on trabecular and cortical microarchitecture. 
Trabecular (D) bone volume fraction and (E) thickness of cre-negative and Vhl cKO mice. Quantification of 
femoral mid-diaphyseal cortical (F) tissue cross-sectional area, (G) cortical bone area, (H), cortical thickness, 
and (I) polar moment of inertia in cre-negative or Vhl cKO mice. n=7 per genotype; groups with different letters 
are statistically different from each other. 
Figure 3. Osteocytic Hif1a does not influence skeletal development. (A) microCT images of cortical and 
trabecular microarchitecture from cre-negative and osteocytic Hif1a cKO distal femora. (B) Distal metaphyseal 
trabecular bone volume fraction, (C) cortical area fraction, and (D) bone formation rate were each unaffected 
by deletion of osteocytic Hif1a. n=5-7 per genotype; groups with different letters are statistically different from 
each other. 
Figure 4. Influence of Vhl on Wnt signaling and requirement thereof for reversion of Vhl cKO HBM 
phenotype. Representative immunocytochemical staining for (A) sclerostin or activated -catenin in femoral 
mid-diaphyseal cortical bone from cre-negative or Vhl cKO mice. (B) Representative microCT reconstruction of 
distal femora of cre-negative, Vhl cKO, Vhl cKO; Lrp5-/- or Vhl cKO; SOSTTG mice. Distal metaphyseal 
trabecular (C) bone volume fraction and (D) thickness or mid-diaphyseal cortical (E) thickness and (F) cortical 
area fraction of cre-negative, Vhl cKO, Vhl cKO; Lrp5-/- or Vhl cKO; SOSTTG mice. n=2-11 mice per genotype; 
groups with different letters are statistically different from each other. 
Figure 5. Influence of osteocytic Vhl deletion on B cell lymphopoiesis in bone marrow and spleen. (A) 
Femoral cortical marrow area as determined by µCT. (B) Total numbers of bone marrow CD45+ hematopoietic 
cells. (C) Representative flow cytometry plots analyzing B cell developmental stages in control and Vhl cKO 
mice. (D) Bone marrow B cell precursor, immature, and mature B lymphocyte frequency in cre-negative and 
Vhl cKO mice. (E) Mean frequencies of LSK hematopoietic progenitors in the bone marrow and spleen of 
controls and Vhl cKO mice. (F) Gating strategy on live Cd11b-Gr1- cells for splenic B cell populations.  (G) 
Mean frequencies of IgM-IgD- and IgM+IgDhigh subsets within CD19int B220int splenic B cells; (H) Mean 
frequencies ofIgM-IgD-, IgM+IgDlow, and IgM+/-IgDhigh subsets within CD19int B220int splenic B cells. N=10 mice 
per genotype; groups with different letters are statistically different from each other. 
Supplemental Figure 1. (A) Representative negative control, without primary antibody, for 
immunocytochemistry. (B) L4 vertebrae from 16-week old male cre-negative or Vhl cKO mice. 
Supplemental Figure 2. Osteocytic Vhl cKO mice have improved skeletal microarchitecture. (A) 
Trabecular spacing, (B) trabecular number, and (C) cortical area fraction in 16-week old male cre-negative or 
Vhl cKO femora. (D) MacNeal’s/Von Kossa staining of the undemineralized distal femur from cre-negative or 
Vhl cKO mice reveal abundant mineralized tissue (black) in mutant compared to control mice. (E) Toluidine 
blue staining of thin sections from the same groups panel D show that the dense mineralized tissue is bone 
and not calcified cartilage from the growth plate that failed to remodel. n=7 per genotype; groups with different 
letters are statistically different from each other. 
Supplemental Figure 3. Absence of skeletal phenotype in osteocytic Hif1a cKO mice. Representative 
microCT images illustrate that deletion of osteocytic Hif1a has no influence on (A) trabecular number, (B) 
trabecular spacing, (C) cortical total area, (D) cortical bone area, (E) cortical thickness, (F) mineralizing surface 
per bone surface, (G) endosteal and periosteal mineral apposition rate, or (H) endosteal and periosteal bone 
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formation rate. n=4-10 animals per genotype; groups with different letters are statistically different from each 
other. 
Supplemental Figure 4. Absence of apparent remodeling deficits in osteocytic Hif1a cKO mice. (A) 
Tissue mineralization in cre-negative or Hif1a cKO mice, visualized by MacNeal’s/Von Kossa; (B) TRAP-
stained osteoclasts were found in both cre-negative and Hif1a cKO sections.  
Supplemental Figure 5. Trabecular and cortical microarchitecture in compound Vhl/Wnt signaling 
mutant mice. (A) Quantification of osteocytes staining positively for sclerostin or activated -catenin in cre-
negative or Vhl cKO femoral mid-diaphyseal cortical bone.Quantification of (B) trabecular number and (C) 
trabecular spacing in femoral distal metaphysis of mice with indicated genotypes. (D) cortical area fraction and 
(E) polar moment of inertia in mid-diaphyseal femoral cortical bone of mice with indicated genotypes. n=2-6
animals per genotype; groups with different letters are statistically different from each other.
Supplemental Figure 6. B cell development in bone marrow and spleen of cre-negative and osteocytic 
Vhl cKO mice. (A) Absolute numbers of B cell precursors, immature and mature B lymphocytes in the bone 
marrow of control and Vhl cKO mice. Total number of LSK cells in (B) bone marrow and (C) spleens of cre-
negative and Vhl cKO mice. Groups with different letters are statistically different from each other 
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TABLE 1. 
CD45+ Population 
(mean % ± SD) 
Control 
(n=10) 
Vhl cKO 
(n=10) 
Bone marrow 
B lymphocytes 
(total CD19+)  
26.76 ± 8.38 12.85 ± 3.25 *** 
T lymphocytes 
(total CD3+) 
1.54 ±.0.85 1.67 ±.1.98 
Monocytes  
(CD11b+ Gr1low) 
5.12 ±.1.75 6.70 ±.1.38* 
Granulocytes 
(CD11b+ Gr1high) 
55.77 ±.7.80 66.46 ±.5.34** 
Spleen 
B lymphocytes 
(total CD19+) 
59.51 ±.7.62 37.24 ±.13.28*** 
T lymphocytes 
(total CD3+) 
23.84 ±.2.80 20.04 ±.8.30 
Monocytes 
(CD11b+ Gr1low) 
2.93 ±.0.42 4.47 ±.1.06*** 
Granulocytes 
(CD11b+ Gr1high) 
2.09 ±.0.59 12.34 ±.8.51** 
*p<0.05, ** p<0.01, ǂ p=0.06
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HIGHLIGHTS 
 Osteocytes—the terminally differentiated cells in bone—exert a robust influence on bone mass through
their capacity to perceive pericellular oxygen.
 In contrast to reports using osteoprogenitors, osteocytes do not require Hif1a, suggesting a differentiation-
dependent need for and use of HIF-alpha subunits.
 Influencing oxygen availability drives canonical Wnt signaling in bone, a current target of pharmacologic
intervention to improve bone mass and prevent age-related osteoporosis.
 Absence of osteocytic Vhl reduces B cell maturation in bone marrow.
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